FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1490642457> ?p ?o ?g. }

• W1490642457 abstract "Transient tachypnea of the newborn (TTN) is caused by delayed clearance of lung fluid at birth. TTN typically appears within the first two hours of life in term and late preterm neonates and is characterized by tachypnea and signs of respiratory distress. Although it is usually a self-limited condition, admission to a neonatal unit is frequently required for monitoring and providing respiratory support. Restricting intake of fluids administered to these infants in the first days of life might improve clearance of lung liquid, thus reducing the effort required to breathe, improving respiratory distress, and potentially reducing the duration of tachypnea.To evaluate the efficacy and safety of restricted fluid therapy as compared to standard fluid therapy in decreasing the duration of oxygen administration and the need for noninvasive or invasive ventilation among neonates with TTN.We used the standard search strategy of Cochrane Neonatal to search the Cochrane Central Register of Controlled Trials (CENTRAL; 2019, Issue 12), in the Cochrane Library; Ovid MEDLINE and electronic ahead of print publications, in-process & other non-indexed citations, Daily and Versions(R); and the Cumulative Index to Nursing and Allied Health Literature (CINAHL), on December 6, 2019. We also searched clinical trial databases and the reference lists of retrieved articles for randomized controlled trials and quasi-randomized trials.We included randomized controlled trials (RCTs), quasi-RCTs, and cluster trials on fluid restriction in term and preterm neonates with the diagnosis of TTN or delayed adaptation during the first week after birth.For each of the included trials, two review authors independently extracted data (e.g. number of participants, birth weight, gestational age, duration of oxygen therapy, need for continuous positive airway pressure [CPAP], need for mechanical ventilation, duration of mechanical ventilation) and assessed the risk of bias (e.g. adequacy of randomization, blinding, completeness of follow-up). The primary outcome considered in this review was the duration of supplemental oxygen therapy in hours or days. We used the GRADE approach to assess the certainty of evidence.Four trials enrolling 317 infants met the inclusion criteria. Three trials enrolled late preterm and term infants with TTN, and the fourth trial enrolled only term infants with TTN. Infants were on various methods of respiratory support at the time of enrollment including room air, oxygen, or nasal CPAP. Infants in the fluid-restricted group received 15 to 20 mL/kg/d less fluid than those in the control group for varying durations after enrollment. Two studies had high risk of selection bias, and three out of four had high risk of performance bias. Only one study had low risk of detection bias, with two at high risk and one at unclear risk. The certainty of evidence for all outcomes was very low due to imprecision of estimates and unclear risk of bias. Two trials reported the primary duration of supplemental oxygen therapy. We are uncertain whether fluid restriction decreases or increases the duration of supplemental oxygen therapy (mean difference [MD] -12.95 hours, 95% confidence interval [CI] -32.82 to 6.92; I² = 98%; 172 infants). Similarly, there is uncertainty for various secondary outcomes including incidence of hypernatremia (serum sodium > 145 mEq/L, risk ratio [RR] 4.0, 95% CI 0.46 to 34.54; test of heterogeneity not applicable; 1 trial, 100 infants), hypoglycemia (blood glucose < 40 mg/dL, RR 1.0, 95% CI 0.15 to 6.82; test of heterogeneity not applicable; 2 trials, 164 infants), endotracheal ventilation (RR 0.73, 95% CI 0.24 to 2.23; I² = 0%; 3 trials, 242 infants), need for noninvasive ventilation (RR 0.40, 95% CI 0.14 to 1.17; test of heterogeneity not applicable; 2 trials, 150 infants), length of hospital stay (MD -0.92 days, 95% CI -1.53 to -0.31; test of heterogeneity not applicable; 1 trial, 80 infants), and cumulative weight loss at 72 hours of age (%) (MD 0.24, 95% CI -1.60 to 2.08; I² = 89%; 2 trials, 156 infants). We did not identify any ongoing trials; however, one trial is awaiting classification.We found limited evidence to establish the benefits and harms of fluid restriction in the management of TTN. Given the very low certainty of available evidence, it is impossible to determine whether fluid restriction is safe or effective for management of TTN. However, given the simplicity of the intervention, a well-designed trial is justified." @default.
• W1490642457 created "2016-06-24" @default.
• W1490642457 creator A5036686823 @default.
• W1490642457 creator A5040887308 @default.
• W1490642457 creator A5051439307 @default.
• W1490642457 date "2021-02-18" @default.
• W1490642457 modified "2023-10-02" @default.
• W1490642457 title "Fluid restriction in the management of transient tachypnea of the newborn" @default.
• W1490642457 cites W1482099777 @default.
• W1490642457 cites W1490642457 @default.
• W1490642457 cites W1516055747 @default.
• W1490642457 cites W1520130256 @default.
• W1490642457 cites W1862283115 @default.
• W1490642457 cites W1920988452 @default.
• W1490642457 cites W1970462406 @default.
• W1490642457 cites W1978006650 @default.
• W1490642457 cites W1981871561 @default.
• W1490642457 cites W1988201000 @default.
• W1490642457 cites W1989429317 @default.
• W1490642457 cites W1996830933 @default.
• W1490642457 cites W2001985093 @default.
• W1490642457 cites W2003598129 @default.
• W1490642457 cites W2021868811 @default.
• W1490642457 cites W2030795695 @default.
• W1490642457 cites W2036301159 @default.
• W1490642457 cites W2049108896 @default.
• W1490642457 cites W2054002931 @default.
• W1490642457 cites W2056831759 @default.
• W1490642457 cites W2057552405 @default.
• W1490642457 cites W2088458089 @default.
• W1490642457 cites W2100898374 @default.
• W1490642457 cites W2101299963 @default.
• W1490642457 cites W2104272943 @default.
• W1490642457 cites W2119453812 @default.
• W1490642457 cites W2139427336 @default.
• W1490642457 cites W2141470156 @default.
• W1490642457 cites W2162531869 @default.
• W1490642457 cites W2174198429 @default.
• W1490642457 cites W2323735264 @default.
• W1490642457 cites W2413260744 @default.
• W1490642457 cites W2567362164 @default.
• W1490642457 cites W2810556197 @default.
• W1490642457 cites W2896502144 @default.
• W1490642457 cites W3026057352 @default.
• W1490642457 cites W4246008226 @default.
• W1490642457 doi "https://doi.org/10.1002/14651858.cd011466.pub2" @default.
• W1490642457 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/8094737" @default.
• W1490642457 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/33599990" @default.
• W1490642457 hasPublicationYear "2021" @default.
• W1490642457 type Work @default.
• W1490642457 sameAs 1490642457 @default.
• W1490642457 citedByCount "12" @default.
• W1490642457 countsByYear W14906424572020 @default.
• W1490642457 countsByYear W14906424572021 @default.
• W1490642457 countsByYear W14906424572022 @default.
• W1490642457 countsByYear W14906424572023 @default.
• W1490642457 crossrefType "journal-article" @default.
• W1490642457 hasAuthorship W1490642457A5036686823 @default.
• W1490642457 hasAuthorship W1490642457A5040887308 @default.
• W1490642457 hasAuthorship W1490642457A5051439307 @default.
• W1490642457 hasBestOaLocation W14906424572 @default.
• W1490642457 hasConcept C126322002 @default.
• W1490642457 hasConcept C141983124 @default.
• W1490642457 hasConcept C168563851 @default.
• W1490642457 hasConcept C177713679 @default.
• W1490642457 hasConcept C187212893 @default.
• W1490642457 hasConcept C2776478404 @default.
• W1490642457 hasConcept C2778312941 @default.
• W1490642457 hasConcept C2780283014 @default.
• W1490642457 hasConcept C2780630273 @default.
• W1490642457 hasConcept C42219234 @default.
• W1490642457 hasConcept C44249647 @default.
• W1490642457 hasConcept C71924100 @default.
• W1490642457 hasConcept C82789193 @default.
• W1490642457 hasConcept C95190672 @default.
• W1490642457 hasConceptScore W1490642457C126322002 @default.
• W1490642457 hasConceptScore W1490642457C141983124 @default.
• W1490642457 hasConceptScore W1490642457C168563851 @default.
• W1490642457 hasConceptScore W1490642457C177713679 @default.
• W1490642457 hasConceptScore W1490642457C187212893 @default.
• W1490642457 hasConceptScore W1490642457C2776478404 @default.
• W1490642457 hasConceptScore W1490642457C2778312941 @default.
• W1490642457 hasConceptScore W1490642457C2780283014 @default.
• W1490642457 hasConceptScore W1490642457C2780630273 @default.
• W1490642457 hasConceptScore W1490642457C42219234 @default.
• W1490642457 hasConceptScore W1490642457C44249647 @default.
• W1490642457 hasConceptScore W1490642457C71924100 @default.
• W1490642457 hasConceptScore W1490642457C82789193 @default.
• W1490642457 hasConceptScore W1490642457C95190672 @default.
• W1490642457 hasIssue "2" @default.
• W1490642457 hasLocation W14906424571 @default.
• W1490642457 hasLocation W14906424572 @default.
• W1490642457 hasLocation W14906424573 @default.
• W1490642457 hasOpenAccess W1490642457 @default.
• W1490642457 hasPrimaryLocation W14906424571 @default.
• W1490642457 hasRelatedWork W1975755487 @default.
• W1490642457 hasRelatedWork W2139520708 @default.
• W1490642457 hasRelatedWork W2381982637 @default.
• W1490642457 hasRelatedWork W2422993843 @default.
• W1490642457 hasRelatedWork W2802322663 @default.

• next